1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF445 CTRPv2 pan-cancer AAC 0.27 6e-14
mRNA FAM117B CTRPv2 pan-cancer AAC 0.25 2e-13
mRNA PBRM1 CTRPv2 pan-cancer AAC 0.26 6e-13
mRNA NASP CTRPv2 pan-cancer AAC 0.23 2e-12
mRNA DOT1L CTRPv2 pan-cancer AAC 0.28 3e-12
mRNA MYOF CTRPv2 pan-cancer AAC -0.26 5e-12
mRNA PRR36 CTRPv2 pan-cancer AAC 0.23 1e-11
mRNA KHDRBS1 CTRPv2 pan-cancer AAC 0.23 2e-11
mRNA MEX3A CTRPv2 pan-cancer AAC 0.27 2e-11
mRNA HACE1 CTRPv2 pan-cancer AAC 0.22 2e-11
Download CSV